Aspen Australia
OVERALL |
|
Owned |
ZAF |
Rating |
![]() |
Pharmaceuticals
Aspen commenced operations in Australia in May 2001 and since then has acquired many established brands of medicines. They operate four manufacturing plants in Australia. Bought the Sigma pharmaceuticals business in 2011, taking over the Herron brand. Aspen acquired a portfolio of 25 products from GSK for the Australian market in 2012. Sold Herron to Perrigo in 2014.
Company Ownership
Aspen Asia Pacific Pty Ltd | AUS | website | ||||
Aspen Pharmacare Holdings Ltd ![]() owns 100% of Aspen Asia Pacific Pty Ltd |
ZAF | website | ||||
Pharmaceutical manufacturer Based in South Africa, Aspen are Africa's largest pharmaceutical manufacturer, and the ninth largest pharmaceutical company in the world. Aspen has businesses in Australia, India, South Africa, the United Kingdom and a start-up operation in the United States. Products available in more than 150 countries. GlaxoSmithKline acquired a 19% stake in 2009, which it reduced to 12% in 2013, and further reduced to 6% in 2015. |
Company Assessment
PRAISE | CRITICISM | INFORMATION | ||
Aspen Asia Pacific Pty Ltd | ||||
This company received a packaging performance level of 3 (Advanced) in its 2023 APCO Annual Report. Australian Packaging Covenant Organisation (APCO) is a not-for-profit organisation leading the development of a circular economy for packaging in Australia. Each year, APCO Members are required to submit an APCO Annual Report and Action Plan, which includes an overall performance level from 1 (Getting Started) to 5 (Beyond Best Practice).
Source: APCO (2023) |
In 2014 and 2012 the Therapeutic Goods Administration's Complaints Resolution Panel upheld complaints about ads by this company on the grounds that they breached advertising codes. The Panel requested this company withdraw the ads and not to use representations in the ads again.
Source: TGA Complaints Register (2014)
Named and shamed in the 2014 CHOICE Shonky Awards. S-26 Gold Toddler and Junior powdered milk formula proclaims it provides 'nutritional support for young kids', even though health professionals advise that toddler and junior milks aren't needed for healthy kids over the age of one. It used the following wording in marketing to retailers in an industry trade magazine: 'Keep mums buying with our extended range of nutritious milk drinks'.
Source: Choice (2014)
This company is a signatory to the Manufacturers and Importers Agreement 1992 (MAIF), a voluntary self-regulatory code of conduct between the manufacturers and importers of infant formula in Australia. The MAIF Agreement aims to contribute to the provision of safe and adequate nutrition for infants, by the protection and promotion of breastfeeding and by ensuring the proper use of breast milk substitutes, when they are necessary, on the basis of adequate information through appropriate marketing and distribution.
Source: Australian Govt Dept of Health (2019)
Human Rights Law Centre's 2022 report, "Broken Promises: Two years of corporate reporting under Australia's Modern Slavery Act", examines statements submitted to the Government's Modern Slavery Register by 92 companies sourcing from four sectors with known risks of modern slavery: garments from China, rubber gloves from Malaysia, seafood from Thailand and fresh produce from Australia. Modern slavery statements are analysed to see if they comply with the mandatory reporting requirements, identify or disclose obvious modern slavery risks, and demonstrate effective actions to address risks. This company's modern slavery disclosure statement received a rating in the 41-60% range. The average score was 44% and the highest score was 89%.
Source: Human Rights Law Centre (2022) |
|||
Aspen Pharmacare Holdings Ltd | ||||
In 2022, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of B.
Source: CDP (2022)
In 2022, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security Score of B-.
Source: CDP (2022) |
This company is named and shamed in IBFAN's 2017 report, 'Breaking the Rules, Stretching the Rules 2017', evidence of violations of the International Code of Marketing of Breastmilk Substitutes, compiled from June 2014 to June 2017. The report covers 792 Code violations from 79 countries and by 28 companies.
Source: IBFAN (2017)
The 2022 Nature Benchmark ranks 400 companies across eight industries on their efforts to protect our environment and its biodiversity. The companies were assessed using three measurement areas: governance and strategy; social inclusion and community impact; and ecosystems and biodiversity. This company ranked #184/400, with a total score of 15.6/100.
Source: World Benchmarking Alliance (2022) |
Follow the link to view relevant documents which support this company's sustainability claims.
Source: company website (2015)
The United Nations Global Compact asks companies to embrace, support and enact, within their sphere of influence, a set of 10 values in the areas of human rights, labour standards, the environment, and anti-corruption. However it's non-binding nature has been widely criticised, and many signatory corporations continue to violate the Compact's values.
Source: UN Global Compact (2020)
This company received an S&P Global ESG Score of 42/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 23 Sep 2022). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Source: S&P Global (2022) |
Company Details
Type | Wholly-owned subsidiary |
Employees | 823 (2013) |
Aus Manufacturing | Yes |
Contact Details
Address | 34-36 Chandos St, St Leonards, NSW , 2065, Australia |
Phone | 02 8436 8300 |
aspen@aspenpharmacare.com.au | |
Website | www.aspenpharma.com.au |